The KAITEKI Institute, Inc. is a global research institute focused on meeting 21st century challenges in energy, the environment, and healthcare.
"Kaiteki," which traditionally means "comfort" or "ease" in Japanese, was chosen for the Institute's name to represent the global quality of life that will be made possible through sustainable technologies and through breakthrough scientific advances in human healthcare.
The Institute will not only fund the highest quality of scientific and engineering research around the world—it will also identify and articulate future societal trends, needs, and challenges, which will be used to set subsequent research targets.
The KAITEKI Institute will propose solutions based on promising research results as new technology platforms within the research arms or businesses of the Mitsubishi Chemical Holdings Group.
The Institute will help make society healthier, more comfortable, and more affluent by supporting long-term R&D and business strategy for the Mitsubishi Chemical Holdings Group, while taking advantage of a global scientific and information network.
Yoshimitsu Kobayashi is Chairman of Mitsubishi Chemical Holdings Corporation (MCHC). Dr. Kobayashi received an M.S. in interdisciplinary science from the University of Tokyo in 1971, then studied as a government-sponsored foreign student in radiation physics at Hebrew University of Jerusalem, Israel in 1972, and in radiation physics at the Scuola Normale Superiore in Pisa, Italy in 1973, and received a Ph.D. in radiation physics from the University of Tokyo in 1975. He joined Mitsubishi Chemical Industries Limited (currently Mitsubishi Chemical Corporation) in 1974, and was named President of Mitsubishi Kagaku Media Co., Ltd. and General Manager of Information Storage Products Department in 1996. He went on to hold positions as Chief Technology Officer, Managing Executive Officer of Mitsubishi Chemical Corporation, and President and Chief Executive Officer of Mitsubishi Chemical Group Science and Technology Research Center, Inc., then became president and CEO of MCHC in 2007. He also assumed the role of President of The KAITEKI Institute in April 2009. He became Chairman of our institute on February 1, 2015, and chairman of MCHC in April, 2015.
Kuniaki Kaga graduated from the faculty of Pharmaceutical Sciences of the University of Tokyo in 1975, and then joined Mitsubishi Chemical Industries Limited (current Mitsubishi Chemical Corporation). He was named General Manager of the company’s Healthcare Planning Division in 2004, and then became Executive Officer and General Manager of the Healthcare Strategy Office of Mitsubishi Chemical Holdings Corporation in 2006. Mr. Kaga became Senior Managing Executive Officer and Chief Operation Officer of the Research Division of Mitsubishi Tanabe Pharma Corporation in 2012. In 2014, he became President of the Life Science Institute, Inc. and a member of the Board of The KAITEKI Institute. He assumed the current position as President of our institute on February 1, 2015, and also appointed as Chairman of the Advisory Board in April, 2017.